Skip to main content
Premium Trial:

Request an Annual Quote

Chromatide Wins $145K Grant to Develop Enzyme-Immobiliziation Tech

NEW YORK (GenomeWeb News) — Purification products maker Chromatide said today it has won a £70,000 ($145,000) NorthWest Regional Development Agency award to develop enzyme-immobilization technology.
The Cheshire, UK-based company said the technology will lower the cost of immobilizing enzymes, which could simplify drug-development and chemical-production processes.
Don Wellings, the company’s chief scientific officer, said the technology allows the company to “create very effective immobilized enzymes … which can be used to simplify the use of biotransformation processes in a range of industries.”

The Scan

US Booster Eligibility Decision

The US CDC director recommends that people at high risk of developing COVID-19 due to their jobs also be eligible for COVID-19 boosters, in addition to those 65 years old and older or with underlying medical conditions.

Arizona Bill Before Judge

The Arizona Daily Star reports that a judge weighing whether a new Arizona law restricting abortion due to genetic conditions is a ban or a restriction.

Additional Genes

Wales is rolling out new genetic testing service for cancer patients, according to BBC News.

Science Papers Examine State of Human Genomic Research, Single-Cell Protein Quantification

In Science this week: a number of editorials and policy reports discuss advances in human genomic research, and more.